IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 401 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $29,000 | +52.6% | 352 | 0.0% | 0.01% | +50.0% |
| Q4 2018 | $19,000 | +35.7% | 352 | +29.4% | 0.01% | +33.3% |
| Q3 2018 | $14,000 | +27.3% | 272 | 0.0% | 0.01% | +50.0% |
| Q2 2018 | $11,000 | -31.2% | 272 | -26.7% | 0.00% | -33.3% |
| Q1 2018 | $16,000 | -44.8% | 371 | -35.0% | 0.01% | -45.5% |
| Q4 2017 | $29,000 | -78.7% | 571 | -78.8% | 0.01% | -79.2% |
| Q3 2017 | $136,000 | +1.5% | 2,690 | +2.1% | 0.05% | -5.4% |
| Q2 2017 | $134,000 | +26.4% | 2,635 | 0.0% | 0.06% | +21.7% |
| Q1 2017 | $106,000 | -20.3% | 2,635 | -5.0% | 0.05% | -24.6% |
| Q4 2016 | $133,000 | +54.7% | 2,775 | +18.5% | 0.06% | +52.5% |
| Q3 2016 | $86,000 | +21.1% | 2,341 | -22.7% | 0.04% | +17.6% |
| Q2 2016 | $71,000 | -41.8% | 3,029 | 0.0% | 0.03% | -42.4% |
| Q1 2016 | $122,000 | -15.3% | 3,029 | +29.9% | 0.06% | -7.8% |
| Q4 2015 | $144,000 | – | 2,332 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |